The Regional Center for Women in the Arts

is a 501 (c) (3) non profit corporation formed in 2000.

Our Story extends beyond the borders of Delaware and Chester Counties in Pennsylvania, our center of operations. It began in 1998 when artist Valetta purchased a house with the dream of converting it into a special kind of art center. Out of this dream rose the R.C.W.A.

Our Mission and Goals are to serve and enrich the community by raising money for charities that benefit women in need, highlighting the work of the best regional women artists, providing a library for the study of women in the arts, presenting lectures and panel discussions about women's arts issues, and providing a space for visiting artists and lecturers.

Our Exhibitions and Programs: (selected list)

brigitte goutal admires shirt
alan soffer uses a paint tube

^ Brigitte Goutal admires shirt

RCWA PAINTING PARTY MAY, 2013

barb suplee paints on the wall  

^ Barb Suplee paints on wall 

Alan Soffer uses paint tube>              

carol cole speaks about her prize winning sculpture

December 11, 2012

Carol Cole speaks about her prize winning sculpture at the Delaware Center for Horticulture at our luncheon in Wilmington, DE. Also seen are the Blue Line by Tatana Kellner and an installation by Nancy Sarangoulis.  Funds were raised for the Baylor Women's Garden program.

Deb Hagan on the set of "Pee Shy" winner of the award, 2005

Effexor XR is used for treating depression, generalized or social anxiety disorder, or panic disorder.

Effexor xr $0.77 - pills Per pill
Effexor xr $0.77 - pills Per pill
Effexor xr $0.98 - pills Per pill
Effexor xr $1.01 - pills Per pill
Effexor xr $1.83 - pills Per pill





Effexor dosage 37.5 mg/day or 75 mg/day. For patients who had taken any dosage of exemestane or combination and tretinoin in the previous 7 days, dosage was reduced by 25% to 50% in order reduce the risk effexor price uk of tretinoin-associated neovascularization as assessed at the evaluation visit. average dosage of exemestane was increased to 100 mg/day or 200 in order to avoid a dose increase of exemestane, which potentially led to an increase in the incidence of neovascularization during study. The study was open label and conducted under the supervision of a local investigator. All patients signed informed consent forms approved by the Institutional Review Board (IRB) of the National Institutes Health and Food Drug Administration (FDA). All patients gave written informed consent before study participation. Outcome Measures All study participants effexor xr 37.5 mg price completed baseline measurements of height, weight, percentage body fat, and serum levels of total free and phospholipid fatty acids. Serum levels of total cholesterol, high-density lipoprotein triglycerides, and low-density cholesterol were determined before starting study treatment with exemestane, tretinoin or two other study medications. All participants also gave a pre-treatment physical examination. The primary efficacy endpoint was incidence of abnormal clinical exam abnormalities as defined by the presence of abnormal features on clinical examination, as well the occurrence of neovascularization during study, which may be indicative of the development a new neovascularization. After the completion of initial 3-month study period, a 2-month follow-up visit was undertaken to assess the safety of study drug. The primary efficacy endpoint was a mean change in the score for presence of abnormal features on clinical examination as defined by the presence of abnormal features on clinical examination (≥ 100% increases). The change from baseline in a total score of 0 was defined as the criterion for a favorable clinical outcome. The secondary efficacy endpoint was presence of neovascularization on clinical examination as measured by the occurrence of neovascular lesions as defined by the presence of neovascular lesions on clinical examination (≥ 50% increases) or by clinical examination abnormalities defined Drug store online shopping the presence of neovascular lesions on clinical examination (≥ 50% increases) or by clinical examination abnormalities defined the presence of neovascular lesions on clinical examination (≥ 50% increases). The mean clinical effects of exemestane or and tretinoin were assessed by the presence or absence of adverse events on clinical examination. The number of adverse events interest was calculated by multiplying the number of adverse events by the proportion of patients receiving study treatment. Statistical Analysis The prevalence of adverse events interest was compared between the two treatment groups using mixed-effects linear regression model. This model allows for the interaction of study group and the treatment with respect to specific outcome (ie, neovascularization). The proportional hazards assumption was assessed using the method of Kaplan–Meier curves. log-rank test was used to determine differences in the number best online pharmacy to buy pain meds of adverse events between the two groups. significance level was set at p<0.05. All statistical analyses were performed using Analysis Systems (SAS version 9.2, SAS Institute Inc, Cary, NC). Results The study population included 1,069 patients (1,023 women, median age, 61 years, range, 34-104 years) who were randomly assigned to receive exemestane or tretinoin. The proportion of patients in exemestane group that discontinued treatment was approximately 30% with an average follow-up of 9.5 months (range, 0-16 months). Fildena online pharmacy There was no difference in the mean length of time treatment in the exemestane and tretinoin groups (P = 0.45, Table 1). In addition, no serious adverse events occurred in either the tretinoin or exemestane groups during the study period. Table 1. Exemestane (N = 628) and tretinoin 629) P Valuea n Mean (SD) Median